Neuroscience Market Report by Component (Instruments and Consumables, Software and Services), Technology (Brain Imaging, Neuro-Microscopy, Electrophysiology, Neuroproteomic Analysis, Animal Behaviour Analysis, and Others), End User (Hospitals, Diagnostic Laboratories, Research and Academic Institutes, and Others), and Region 2025-2033

Neuroscience Market Report by Component (Instruments and Consumables, Software and Services), Technology (Brain Imaging, Neuro-Microscopy, Electrophysiology, Neuroproteomic Analysis, Animal Behaviour Analysis, and Others), End User (Hospitals, Diagnostic Laboratories, Research and Academic Institutes, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A5133

Neuroscience Market Size:

The global neuroscience market size reached USD 35.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 48.0 Billion by 2033, exhibiting a growth rate (CAGR) of 3.1% during 2025-2033. Increasing prevalence of neurological disorders, rising investment in research and development (R&D), technological advancements in neuroimaging tools, growing awareness of mental health issues, expanding applications in neuroinformatics and neuroprosthetics, burgeoning aging populations, and supportive government policies are some of the factors facilitating the market growth.

Report Attribute 
Key Statistics
Base Year
2024
Forecast Years
2025-2033
Historical Years
2019-2024
Market Size in 2024
USD 35.9 Billion
Market Forecast in 2033
USD 48.0 Billion
Market Growth Rate 2025-2033 3.1%


Neuroscience Market Analysis:

  • Major Market Drivers: Based on the neuroscience market analysis, one key driver of market expansion is the increased funding put into research and development (R&D) efforts, by industry players and research institutions aimed to create treatments. Another contributing factor to market growth is the rising occurrence of disorders including epilepsy. In line with this, the escalating prevalence of neurological ailments in aging population has surged the demand for new treatments options, which is further providing a considerable thrust to the market growth. The market is also supported by the investments by the governments of various nations to support research and growing collaborative activities among industries and academia.
  • Key Market Trends: The neuroscience market is growing due to the rising prevalence of neurological disorders like Alzheimer's, brain cancer, and epilepsy. For example, Alzheimer's cases are expected to reach 13 Million in the US by 2050. Technological advancements, such as the US BRAIN initiative, are driving research into brain diseases. Digital healthcare innovations are enhancing management and boosting the adoption of neuroscience devices. Furthermore, increased public awareness, as highlighted by initiatives such as "Neuroscience Is" by the American Academy of Neurology, is expanding the market. However, the COVID-19 pandemic temporarily slowed growth due to disruptions in healthcare services.
  • Geographical Trends: North America is at the forefront of advancements in neuroscience due to investments in research and development (R&D), an incidence of neurological disorders and a well-established healthcare system. The United States hosts companies and research institutions that fuel innovation and market expansion. In Europe, countries such as Germany, the UK and France play a role in neuroscience research, with government backing and efficient healthcare systems. The Asia Pacific region is witnessing progress driven by increased healthcare spending, a growing population and heightened awareness of neurological conditions.
  • Competitive Landscape: The competitive landscape of the market is characterized by the presence of key neuroscience companies, such as Alpha Omega Engineering, Biobserve GmbH, Blackrock Neurotech, Doric Lenses Inc., General Electric Company, Kernel, Laserglow Technologies, Mightex Systems, NeuroNexus Technologies Inc., Noldus Information Technology B.V., Plexon Inc., Prizmatix Ltd. and Siemens AG.
  • Challenges and Opportunities: The neuroscience market encounters umpteen obstacles, such as research and development (R&D) expenses, intricate regulatory processes and the demand for highly trained professionals. The intricacies of disorders create barriers to understanding and creating effective therapies. Moreover, the absence of standards and biomarkers for numerous neurological diseases adds complexity to diagnosing and treating these conditions. Nevertheless, these challenges also bring about opportunities for progress and creativity. Technological advancements, like artificial intelligence (AI) and machine learning (ML) provide novel approaches to analyze and interpret data potentially leading to groundbreaking discoveries.

Neuroscience Market


Neuroscience Market Trends:

Increasing Prevalence of Neurological Disorders

The global rise in neurological conditions such as Alzheimer’s disease, Parkinson’s disease, and epilepsy is a major factor driving the growth of the neuroscience market. In the United States, Alzheimer’s currently affects around 7 million people, and this number is projected to nearly double by 2050. This increase is largely due to the aging population, which is more prone to neurodegenerative diseases. As a result, there is a growing demand for advanced diagnostic tools and effective treatment strategies. This has led to intensified research into the biological mechanisms underlying these disorders, with the goal of developing more targeted and effective therapies. The introduction of AI-powered diagnostic systems, such as the Philips CT 3500 launched in 2023, reflects the rapid innovation in the instrument segment, enhancing the precision and speed of neurological assessments. Moreover, the hospital sector is expected to witness the fastest growth, fueled by a rise in neurological admissions and the expansion of healthcare infrastructure, which is increasing the demand for sophisticated diagnostic and therapeutic solutions.

Rising Investment in Neuroscience Research and Development

The neuroscience field is experiencing a surge in funding from both public institutions and private enterprises. These investments support a wide range of initiatives, from fundamental brain research to the development of advanced technologies, such as brain mapping and neural data integration. Government agencies and philanthropic organizations are particularly focused on understanding brain function and dysfunction, while private companies—especially in the biotech and pharmaceutical sectors—are investing in the development of new drugs and therapies. These investments are also strengthening the consumables segment, with companies such as B. Braun SE and GE Healthcare offering durable, user-friendly products like patient monitors and injectors that enhance the efficiency of neurological care. This financial support is accelerating the pace of scientific discovery and helping to translate research findings into practical clinical applications.

Technological Advancements in Neuroimaging Tools

Recent advancements in neuroimaging technologies—including MRI, PET, and EEG—have significantly improved the diagnosis and monitoring of neurological disorders. These tools now offer higher resolution, faster imaging speeds, and more accurate data analysis through advanced algorithms. This has enabled earlier detection of brain abnormalities and more precise localization of lesions, which is critical for effective treatment planning. Additionally, neuro-microscopy is emerging as a transformative area, with companies like Danaher Corporation and Carl Zeiss AG developing ultra-miniature electronic microscopes that can not only detect but may also help reverse neurological damage. These innovations are expanding the capabilities of clinicians and researchers, making neuroimaging an essential component of modern neuroscience.

Neuroscience Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on the component, technology, and end user.

Breakup by Component:

Neuroscience Market by Components

  • Instruments and Consumables
  • Software and Services

Instruments and consumables accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the component. This includes instruments and consumables and software and services. According to the report, instruments and consumables represented the largest segment.

The instruments and consumables segment is driven by the increasing demand for advanced diagnostic and surgical tools in medical and research settings. Technological advancements such as precision instruments and high-throughput consumables are enhancing efficiency and accuracy in diagnostics and experimental procedures, thereby boosting market growth. Moreover, expanding applications in genomic and proteomic research are driving the need for specialized instruments and consumables tailored for molecular analysis and sample preparation. Furthermore, the segment benefits from rising healthcare expenditure globally, which supports investments in state-of-the-art equipment and disposable consumables that ensure patient safety and procedural efficacy. Additionally, regulatory developments mandating the use of certified instruments and sterile consumables in healthcare facilities are influencing market dynamics, encouraging manufacturers to innovate and comply with stringent quality standards.

Breakup by Technology:

  • Brain Imaging
  • Neuro-Microscopy
  • Electrophysiology
  • Neuroproteomic Analysis
  • Animal Behaviour Analysis
  • Others

Brain imaging accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the technology. This includes brain imaging, neuro-microscopy, electrophysiology, neuroproteomic analysis, animal behaviour analysis, and others. According to the report, brain imaging represented the largest segment.

The brain imaging segment is driven by the increasing demand for advanced diagnostic capabilities in neurological disorders. With conditions such as Alzheimer's disease, Parkinson's disease, and strokes on the rise globally, there is a growing need for accurate and early detection methods to facilitate prompt treatment and management. Technological advancements in imaging modalities like magnetic resonance imaging (MRI), positron emission tomography (PET), and computed tomography (CT) have significantly enhanced resolution, speed, and sensitivity, allowing for detailed visualization of brain structures and functions. These advancements not only enable clinicians to pinpoint abnormalities and track disease progression more effectively but also support the development of personalized treatment plans tailored to individual patient needs. Apart from this, the integration of artificial intelligence (AI) and machine learning (ML) algorithms into brain imaging technologies has further bolstered diagnostic accuracy and efficiency, driving adoption across clinical and research settings.

Breakup by End User:

  • Hospitals
  • Diagnostic Laboratories
  • Research and Academic Institutes
  • Others

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, diagnostic laboratories, research and academic institutes, and others.

The hospitals segment is driven by the increasing demand for specialized healthcare services, advanced medical technologies, and comprehensive patient care. Hospitals are expanding their facilities and services to cater to growing populations and rising healthcare needs, including surgical procedures, emergency care, and chronic disease management. Additionally, advancements in medical treatments and therapies, coupled with the integration of digital health technologies, are enhancing hospital efficiency and patient outcomes. Collaborations with pharmaceutical companies and research institutions further drive innovation in medical treatments and diagnostic capabilities within hospital settings.

The diagnostic laboratories segment is driven by the increasing prevalence of diseases requiring early and accurate diagnosis, such as cancer, cardiovascular disorders, and infectious diseases. Diagnostic labs play a crucial role in disease detection, monitoring, and treatment planning, leveraging advanced diagnostic technologies like molecular diagnostics, next-generation sequencing, and advanced imaging techniques. Moreover, the shift towards personalized medicine and precision diagnostics is driving demand for specialized tests and biomarker analysis, contributing to the growth of diagnostic laboratories worldwide. Collaborations with healthcare providers and research institutes enhance the development and adoption of innovative diagnostic solutions.

The research and academic institutes segment is driven by the expanding scope of scientific research across various disciplines, including medicine, biotechnology, and neuroscience. These institutes contribute significantly to advancements in healthcare through fundamental research, clinical trials, and translational research aimed at developing new therapies, drugs, and medical devices. Funding from government grants, private foundations, and collaborations with pharmaceutical companies supports research initiatives and infrastructure development in academic institutions. Additionally, partnerships with hospitals and diagnostic laboratories facilitate knowledge exchange and the application of research findings in clinical practice, driving innovation and improving patient care globally.

Other healthcare segments, such as clinics and ambulatory surgical centers, are driven by the increasing demand for outpatient services, convenience, and cost-effective healthcare delivery models. These facilities offer specialized medical services, preventive care, and minor surgical procedures outside traditional hospital settings. The rise of chronic diseases, aging populations, and healthcare reforms emphasizing preventive care and outpatient treatments are fueling the growth of clinics and ambulatory centers.

Breakup by Region:

Neuroscience Market Report

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest neuroscience market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The North America regional market is driven by the increasing prevalence of chronic diseases such as cardiovascular diseases, diabetes, and obesity, which have heightened demand for advanced healthcare solutions and medical devices. This dominance is largely due to the significant presence of companies focused on developing, manufacturing, and commercializing devices for diagnosing and treating neurological conditions. For example, in February 2022, CERENOVUS introduced the EMBOGUARD, an advanced balloon guide catheter designed for use in endovascular procedures, particularly for patients with acute ischemic stroke. The Asia Pacific region is projected to experience the fastest growth in the coming years. This growth is fueled by increasing investments in healthcare infrastructure and high levels of healthcare spending, which are driving the expansion of the neuroscience industry. A notable example is China's "China Brain Project" (CBP), launched in September 2022 with an initial investment of USD 746 Million. The project aims to explore the neural basis of cognitive functions, brain-inspired computing, and advancements in diagnosing and treating brain disorders. Such government initiatives are expected to accelerate research and development in neuroscience, further boosting market growth.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the neuroscience include Alpha Omega Engineering, Biobserve GmbH, Blackrock Neurotech, Doric Lenses Inc., General Electric Company, Kernel, Laserglow Technologies, Mightex Systems, NeuroNexus Technologies Inc., Noldus Information Technology B.V., Plexon Inc., Prizmatix Ltd., Siemens AG., etc.

    (Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
     
  • Key players in the neuroscience market are actively engaged in enhancing product innovation and technological advancements to maintain competitiveness and meet evolving consumer demands. They focus on developing more efficient diesel engines with improved fuel efficiency and reduced emissions to comply with stringent environmental regulations globally. These efforts also include integrating advanced monitoring and control systems into their generators to enhance reliability and performance. Additionally, market leaders are expanding their product portfolios to offer a wider range of power capacities and application-specific solutions, catering to diverse industrial and commercial sectors. Strategic partnerships and collaborations with technology providers are also prevalent among key players to leverage expertise in hybrid power solutions that integrate renewable energy sources. Moreover, there is a notable emphasis on expanding their geographical presence through acquisitions and joint ventures, particularly in emerging markets like Asia Pacific and Latin America, where demand for reliable power solutions is growing rapidly. 

Neuroscience Market News:

  • In 2021: Blackrock Neurotech announced a significant breakthrough with the development of their new wireless brain-computer interface (BCI) system. This system, designed for both clinical and research applications, enables real-time monitoring and modulation of neural activity without the need for wired connections. The wireless BCI system enhances patient comfort and mobility during clinical trials and long-term studies, representing a significant advancement in neurotechnology.
  • In 2022: Kernel introduced its latest non-invasive brain recording device, Kernel Flow. This device uses advanced time-domain functional near-infrared spectroscopy (TD-fNIRS) technology to measure brain activity with high spatial and temporal resolution. Kernel Flow is designed to be more accessible and user-friendly, allowing for broader applications in both clinical and consumer neuroscience research.

Neuroscience Market Report Scope:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Billion USD
Scope of the Report Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
  • Component
  • Technology
  • End User
  • Region
Components Covered Instruments and Consumables, Software and Services
Technologies Covered Brain Imaging, Neuro-Microscopy, Electrophysiology, Neuroproteomic Analysis, Animal Behaviour Analysis, Others
End Users Covered Hospitals, Diagnostic Laboratories, Research and Academic Institutes, Others
Regions Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Alpha Omega Engineering, Biobserve GmbH, Blackrock Neurotech, Doric Lenses Inc., General Electric Company, Kernel, Laserglow Technologies, Mightex Systems, NeuroNexus Technologies Inc., Noldus Information Technology B.V., Plexon Inc., Prizmatix Ltd., Siemens AG, etc.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Benefits for Stakeholders:

  • IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the neuroscience market from 2019-2033.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the global neuroscience market.
  • The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the neuroscience industry and its attractiveness.
  • The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.

Key Questions Answered in This Report

The global neuroscience market was valued at USD 35.9 Billion in 2024.

We expect the global neuroscience market to exhibit a CAGR of 3.1% during 2025-2033.

The high prevalence of numerous neurological disorders, such as Alzheimer's, schizophrenia, brain stroke, etc., is primarily driving the global neuroscience market.

The sudden outbreak of the COVID-19 pandemic has led to the extensive R&D activities in the field of neuroscience for providing insights into neurological and psychological functioning, that is adversely impacted by the coronavirus disease.

Based on the component, the global neuroscience market has been divided into instruments and consumables and software and services. Currently, instruments and consumables exhibit a clear dominance in the market.

Based on the technology, the global neuroscience market can be segmented into brain imaging, neuro-microscopy, electrophysiology, neuroproteomic analysis, animal behaviour analysis, and others. Among these, brain imaging holds the majority of the total market share.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global neuroscience market include Alpha Omega Engineering, Biobserve GmbH, Blackrock Neurotech, Doric Lenses Inc., General Electric Company, Kernel, Laserglow Technologies, Mightex Systems, NeuroNexus Technologies Inc., Noldus Information Technology B.V., Plexon Inc., Prizmatix Ltd., and Siemens AG.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Neuroscience Market Report by Component (Instruments and Consumables, Software and Services), Technology (Brain Imaging, Neuro-Microscopy, Electrophysiology, Neuroproteomic Analysis, Animal Behaviour Analysis, and Others), End User (Hospitals, Diagnostic Laboratories, Research and Academic Institutes, and Others), and Region 2025-2033
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials